Title |
Virologic outcomes of switching to boosted darunavir plus dolutegravir with respect to history of drug resistance |
|---|---|
Involved |
the DUALIS Study Group (Verfasser)
Eva Wolf (Verfasser) Christoph Boesecke (Verfasser) Annamaria Balogh (Verfasser)
Helen Bidner (Verfasser)
Christiane Cordes (Verfasser) Hans Heiken (Verfasser) Ivanka Krznaric (Verfasser) Tim Kümmerle (Verfasser) Hans-Jürgen Stellbrink (Verfasser) Jochen Schneider (Verfasser) Christoph Daniel Spinner (Verfasser) SpringerLink (Online service) (Sonstige) |
Published in |
AIDS research and therapy 18, 1, 8.9.2021, date:12.2021, Seite 1-5 |
Published |
2021 |
Language |
|
Country |
|
Topic |
|
Subject |
Infectious Diseases. |
DDC notation |
|
Persistent identifier |
urn:nbn:de:101:1-2021112218264721268347 (URN) |
Record ID |
1246252201 |
Please note
The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link: